We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

What Fed. Circ. False Ad Ruling Means For Section 337 Claims

Law360 (May 14, 2019, 4:37 PM EDT) -- In its long-awaited decision in Amarin Pharma. v. U.S. International Trade Commission, the U.S. Court of Appeals for the Federal Circuit provided guidance on the U.S. International Trade Commission’s discretion to decline...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.